Your browser doesn't support javascript.
loading
Recruitment of population-based controls for ALS cases from the National ALS Registry.
Bear, Todd M; Malek, Angela M; Foulds, Abigail; Rager, Judith; Deperrior, Sarah E; Vena, John E; Larson, Theodore C; Mehta, Paul; Horton, D Kevin; Talbott, Evelyn O.
Afiliação
  • Bear TM; Graduate School of Public Health, Department of Behavioral and Community Health Sciences, University of Pittsburgh, Pittsburgh, PA, USA.
  • Malek AM; Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.
  • Foulds A; Graduate School of Public Health, Department of Behavioral and Community Health Sciences, University of Pittsburgh, Pittsburgh, PA, USA.
  • Rager J; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA, and.
  • Deperrior SE; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA, and.
  • Vena JE; Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.
  • Larson TC; Agency for Toxic Substances and Disease Registry, National ALS Registry, Atlanta, GA, USA.
  • Mehta P; Agency for Toxic Substances and Disease Registry, National ALS Registry, Atlanta, GA, USA.
  • Horton DK; Agency for Toxic Substances and Disease Registry, National ALS Registry, Atlanta, GA, USA.
  • Talbott EO; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA, and.
Article em En | MEDLINE | ID: mdl-33860698
ABSTRACT

Objective:

In 2010, the United States Agency for Toxic Substances and Disease Registry (ATSDR) created the National ALS Registry (Registry) to examine the epidemiology of ALS and potential risk factors. We are currently recruiting population-based controls for an epidemiologic case-control study to examine ALS environmental risk factors using this Registry. To date, we have recruited 181 non-diseased, population-based controls for comparison to Registry cases (n = 280). Here we report our recruitment methods for controls and the associated response rates and costs.

Methods:

Eligible ALS cases had complete risk factor survey data, DNA analysis, and blood concentrations of persistent organic pollutants (POPs). Age, sex, and county-matched controls were identified from commercial/consumer databases using a targeted landline phone sample. Eligible controls were consented, surveyed, and mailed the POPs' blood analysis consent form. Once consented, phlebotomy was scheduled.

Results:

We mailed 3760 recruitment letters for 181 potential case-matches across 42 states between 9/2018 and 3/2020. After making phone contact and determining eligibility, 146 controls agreed to participate (response rate = 11.4%, cooperation rate = 22.8%). To date, 127 controls completed the survey and bloodwork. Though controls were matched to cases on age, sex, and county, unmatched characteristics (e.g. smoking) did not differ statistically. Interviewing and incentive costs are estimated at $211.85 per complete participation.

Conclusions:

Recruiting matched population-based controls for comparison to cases from the Registry for a study involving completion of a detailed survey and blood specimen provision is relatively feasible and cost effective. This recruitment method could be useful for case-control studies of other rare disorders.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Lateral Amiotrófica Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Lateral Amiotrófica Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2021 Tipo de documento: Article